drugset / Trial / NCT02345772
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy
NaSingle-groupOpen-labelTreatment
Summary
Hormonal therapy administered before surgery in ER-positive and HER2-positive patients with breast cancer.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 75 mg/m2 | — |
| Subject | Fulvestrant | Small molecule | 500 mg | Intramuscular |
| Subject | Pertuzumab | Monoclonal antibody | 420 mg | — |
| Subject | Trastuzumab | Monoclonal antibody | 6 mg/kg | — |